Trials / Terminated
TerminatedNCT00267839
Effect of Exercise on Risk-factors of Elderly Women
Effects of Exercise on Multiple Risk Factors and Health Costs in Community Living Elderly Women. The Senior Fitness and Prevention Study (SEFIP)
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 246 (actual)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether exercise training may impact relevant risk factors and health costs of community living women older 65 years.
Detailed description
The human aging process is associated with a significant increase of risk factors (i.e. osteoporosis, coronary heard disease, diabetes) and a decline in neuromuscular function impacting independence of the subject. Osteoporosis, diabetes type II and arteriosclerosis are diseases known to correlate with age. Participating in regular sport activities elicits numerous favorable effects that contribute to "healthy aging". Unfortunately all existing studies which focus on specific diseases or conditions favour dedicated exercise regimes. However, the complex risk factor scenario of older adults requires multi-purpose exercise programs with impact on all relevant risks. Furthermore so far no exercise study longitudinally determines the effect of an ambulatory exercise program on health cost considering the specific health policy framework of Germany. We hypothesize that regular exercise 1. significantly impact relevant osteoporosis, cardiovascular diseases and diabetes risk factors in elderly subjects 2. significantly reduces health costs in elderly community living women
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | physical exercise, wellness |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2007-11-01
- Completion
- 2008-03-01
- First posted
- 2005-12-21
- Last updated
- 2015-06-01
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00267839. Inclusion in this directory is not an endorsement.